The online version of this article (doi:10.1186/1471-2261-14-64) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
JHC, GKS, SHK, RK, TA, AI and AGK contributed to the writing of the manuscript. All authors reviewed and approved the final version of the manuscript.
We investigated whether right ventricular dysfunction (RVD) as assessed by echocardiogram can be used as a prognostic factor in hemodynamically stable patients with acute pulmonary embolism (PE). Short-term mortality has been investigated only in small studies and the results have been controversial.
A PubMed search was conducted using two keywords, “pulmonary embolism” and “echocardiogram”, for articles published between January 1st 1998 and December 31st 2011. Out of 991 articles, after careful review, we found 12 articles that investigated the implications of RVD as assessed by echocardiogram in predicting short-term mortality for hemodynamically stable patients with acute PE. We conducted a meta-analysis of these data to identify whether the presence of RVD increased short-term mortality.
Among 3283 hemodynamically stable patients with acute PE, 1223 patients (37.3%) had RVD, as assessed by echocardiogram, while 2060 patients (62.7%) had normal right ventricular function. Short-term mortality was reported in 167 (13.7%) out of 1223 patients with RVD and in 134 (6.5%) out of 2060 patients without RVD. Hemodynamically stable patients with acute PE who had RVD as assessed by echocardiogram had a 2.29-fold increase in short-term mortality (odds ratio 2.29, 95% confidence interval 1.61-3.26) compared with patients without RVD.
In hemodynamically stable patients with acute PE, RVD as assessed by echocardiogram increases short-term mortality by 2.29 times. Consideration should be given to obtaining echocardiogram to identify high-risk patients even if they are hemodynamically stable.
Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N’Gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM: Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011, 378 (9785): 41-48. 10.1016/S0140-6736(11)60824-6. CrossRefPubMed
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR: Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141 (2 Suppl): e419S-e494S. CrossRefPubMedPubMedCentral
Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, Berni G: Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000, 101 (24): 2817-2822. 10.1161/01.CIR.101.24.2817. CrossRefPubMed
Yalamanchili K, Sukhija R, Aronow WS, Sinha N, Fleisher AG, Lehrman SG: Prevalence of increased cardiac troponin I levels in patients with and without acute pulmonary embolism and relation of increased cardiac troponin I levels with in-hospital mortality in patients with acute pulmonary embolism. Am J Cardiol. 2004, 93 (2): 263-264. 10.1016/j.amjcard.2003.09.058. CrossRefPubMed
Sukhija R, Aronow WS, Lee J, Kakar P, McClung JA, Levy JA, Belkin RN: Association of right ventricular dysfunction with in-hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy. Am J Cardiol. 2005, 95 (5): 695-696. 10.1016/j.amjcard.2004.10.055. CrossRefPubMed
Grifoni S, Vanni S, Magazzini S, Olivotto I, Conti A, Zanobetti M, Polidori G, Pieralli F, Peiman N, Becattini C, Agnelli G: Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med. 2006, 166 (19): 2151-2156. 10.1001/archinte.166.19.2151. CrossRefPubMed
Pieralli F, Olivotto I, Vanni S, Conti A, Camaiti A, Targioni G, Grifoni S, Berni G: Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol. 2006, 97 (9): 1386-1390. 10.1016/j.amjcard.2005.11.075. CrossRefPubMed
Jimenez D, Escobar C, Marti D, Diaz G, Vidal R, Taboada D, Ortega J, Moya JL, Barrios V, Sueiro A: Prognostic value of transthoracic echocardiography in hemodynamically stable patients with acute symptomatic pulmonary embolism. Arch Bronconeumol. 2007, 43 (9): 490-494. 10.1157/13109469. CrossRefPubMed
Logeart D, Lecuyer L, Thabut G, Tabet JY, Tartiere JM, Chavelas C, Bonnin F, Stievenart JL, Solal AC: Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med. 2007, 33 (2): 286-292. 10.1007/s00134-006-0482-1. CrossRefPubMed
Palmieri V, Gallotta G, Rendina D, De Bonis S, Russo V, Postiglione A, Martino S, Di Minno MN, Celentano A: Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med. 2008, 3 (2): 131-138. 10.1007/s11739-008-0134-2. CrossRefPubMed
Gallotta G, Palmieri V, Piedimonte V, Rendina D, De Bonis S, Russo V, Celentano A, Di Minno MN, Postiglione A, Di Minno G: Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. Int J Cardiol. 2008, 124 (3): 351-357. 10.1016/j.ijcard.2006.03.096. CrossRefPubMed
Stein PD, Janjua M, Matta F, Pathak PK, Jaweesh F, Alrifai A, Chughtai HL: Prognosis based on creatine kinase isoenzyme MB, cardiac troponin I, and right ventricular size in stable patients with acute pulmonary embolism. Am J Cardiol. 2011, 107 (5): 774-777. 10.1016/j.amjcard.2010.10.061. CrossRefPubMed
Jimenez D, Aujesky D, Moores L, Gomez V, Marti D, Briongos S, Monreal M, Barrios V, Konstantinides S, Yusen RD: Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax. 2011, 66 (1): 75-81. 10.1136/thx.2010.150656. CrossRefPubMed
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB: Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010, 23 (7): 685-713. 10.1016/j.echo.2010.05.010. quiz 786-688 CrossRefPubMed
Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, da Taveira da Silva AM, Come PC, Lee RT, Parker JA, Mogtader A, McDonough TJ, Braunwald E: Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993, 341 (8844): 507-511. 10.1016/0140-6736(93)90274-K. CrossRefPubMed
Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J: Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost. 2014, 12 (4): 459-468. 10.1111/jth.12521. CrossRefPubMed
Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galie N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, et al: Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014, 370 (15): 1402-1411. 10.1056/NEJMoa1302097. CrossRefPubMed
- Right ventricular dysfunction as an echocardiographic prognostic factor in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis
Jae Hyung Cho
Gurusaravanan Kutti Sridharan
Seon Ha Kim
Abraham G Kocheril
- BioMed Central
Neu im Fachgebiet Kardiologie
Mail Icon II